112 related articles for article (PubMed ID: 38144563)
1. Multi-dimension metabolic prognostic model for gastric cancer.
Feng W; Xu B; Zhu X
Front Endocrinol (Lausanne); 2023; 14():1228136. PubMed ID: 38144563
[TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
3. GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.
Xu W; Jiang T; Shen K; Zhao D; Zhang M; Zhu W; Liu Y; Xu C
Front Endocrinol (Lausanne); 2023; 14():1224832. PubMed ID: 37608794
[TBL] [Abstract][Full Text] [Related]
4. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic Value of PCMT1 Expression in Gastric Cancer and Its Regulatory Effect on Spindle Assembly Checkpoints].
Wang Y; Zhang M; Zhang Z; Li B; Huang J; Li J; Geng Z; Zhang X; Song X; Wang L; Zuo L; Hu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1167-1175. PubMed ID: 38162070
[TBL] [Abstract][Full Text] [Related]
7. Combining bulk RNA-sequencing and single-cell RNA-sequencing data to reveal the immune microenvironment and metabolic pattern of osteosarcoma.
Huang R; Wang X; Yin X; Zhou Y; Sun J; Yin Z; Zhu Z
Front Genet; 2022; 13():976990. PubMed ID: 36338972
[No Abstract] [Full Text] [Related]
8. PYCR1 regulates glutamine metabolism to construct an immunosuppressive microenvironment for the progression of clear cell renal cell carcinoma.
Wei X; Zhang X; Wang S; Wang Y; Ji C; Yao L; Song N
Am J Cancer Res; 2022; 12(8):3780-3798. PubMed ID: 36119844
[TBL] [Abstract][Full Text] [Related]
9. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer.
Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L
Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649
[No Abstract] [Full Text] [Related]
10. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
11. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
12. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
13. Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma.
Liu H; Zhang Y; Zhang Q; Zhang T; Lu T
Front Biosci (Landmark Ed); 2023 Dec; 28(12):328. PubMed ID: 38179743
[TBL] [Abstract][Full Text] [Related]
14. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
[TBL] [Abstract][Full Text] [Related]
15. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract][Full Text] [Related]
16. Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways.
Zhu Z; Qin J; Dong C; Yang J; Yang M; Tian J; Zhong X
Bioengineered; 2021 Dec; 12(1):4780-4793. PubMed ID: 34346836
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
18. Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer.
Bian J; Long JY; Yang X; Yang XB; Xu YY; Lu X; Sang XT; Zhao HT
World J Gastroenterol; 2020 Nov; 26(41):6414-6430. PubMed ID: 33244202
[TBL] [Abstract][Full Text] [Related]
19. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer.
Yu Z; Zhu Y; Ji J
Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a 10-gene prognostic model for gastric cancer based on the tumor immune microenvironment.
Yu J; Li T; Han H; Zeng F; Wu Z; Zhang J; Chen Y; Sheng B; Deng S; Zhu P
Anal Biochem; 2022 Oct; 654():114794. PubMed ID: 35777456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
